08/15: StreetInsider.com�s Pre-Open Movers:

Cardiome Pharma Corp. (Nasdaq: CRME) 14% LOWER; said Oxypurinol failed in Phase 2 Trial

This article: 204 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE